Neoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer
1 clinical trials · Condition
◉ Watch Neoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Treatment With Palbociclib and Exemestane Plus Trastuzumab and Pyrotinib in Estrogen Receptor (ER)-Positive, HER2-positive Breast Cancer (NCT04858516) | Guangdong Provincial People's Hospital | 2021-04-30 |
Track Neoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.